表皮生长因子介导小鼠脓毒症生存的作用依赖于完整的适应性免疫系统
该研究在小鼠脓毒症模型中探讨全身或肠道特异性过表达表皮生长因子(EGF)的生存获益是否依赖于适应性免疫系统。脾脏流式细胞术显示,脓毒症后全身给予EGF使CD4+ T细胞频率增加、CD8+ T细胞频率降低,并显著上调活化CD4+ T记忆细胞上的耗竭标志物TIGIT。在缺乏成熟淋巴细胞的Rag1-/-小鼠中,全身EGF显著恶化7天死亡率,且失去改善肠道通透性和绒毛长度的能力;肠道特异性过表达EGF与Rag1-/-杂交后同样对生存无影响。结论提示EGF改善肠道完整性的同时改变T细胞生物学,其脓毒症生存优势至少部分依赖于肠道与适应性免疫系统的相互作用。
要点
- 在免疫健全小鼠中,脓毒症后全身给予EGF可改善生存;但在缺乏成熟淋巴细胞的Rag1-/-小鼠中,全身EGF显著恶化7天死亡率。
- 脓毒症后全身给予EGF使脾脏CD4+ T细胞频率增加、CD8+ T细胞频率降低,并显著减少活化CD4+ T记忆细胞。
- EGF使常规和调节性CD4+ T细胞上的耗竭标志物TIGIT显著上调。
- EGF在Rag1-/-小鼠中仍可减少肠道上皮凋亡,但失去改善肠道通透性和绒毛长度的能力。
- 肠道特异性过表达EGF与Rag1-/-杂交后对脓毒症后生存无影响,尽管仍能减少肠道上皮凋亡和通透性。
适用人群与场景
- 临床前脓毒症小鼠模型,包括免疫健全小鼠、Rag1-/-小鼠(缺乏成熟淋巴细胞)及肠道特异性过表达EGF的转基因小鼠。
研究设计与关键结果
- 研究类型为动物实验;在免疫健全小鼠中,脓毒症后全身给予EGF改善生存。
- 脾脏流式细胞术显示,脓毒症后全身给予EGF使CD4+ T细胞频率增加、CD8+ T细胞频率降低,并显著减少活化CD4+ T记忆细胞。
- EGF使常规和调节性CD4+ T细胞上的耗竭标志物TIGIT显著上调。
- 在Rag1-/-小鼠中,全身EGF显著恶化7天死亡率;EGF仍减少肠道上皮凋亡,但失去改善肠道通透性和绒毛长度的能力。
- 肠道特异性过表达EGF与Rag1-/-小鼠杂交后,对脓毒症后生存无影响,尽管仍能减少肠道上皮凋亡和通透性。
证据类型、等级与局限
- 证据类型:动物实验(小鼠脓毒症模型)。
- 作者结论:EGF通过改善肠道完整性可能成为脓毒症的新型治疗手段,但EGF也改变T细胞生物学,其生存优势至少部分依赖于肠道与适应性免疫系统的相互作用。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该临床前研究提示,在缺乏成熟淋巴细胞的宿主中,全身给予EGF可能恶化脓毒症后7天死亡率,与免疫健全宿主中的生存获益相反。
- 作者认为,EGF通过改善肠道完整性可能是脓毒症的新型治疗手段,但其生存获益至少部分依赖于肠道与适应性免疫系统的相互作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Epidermal growth factor (EGF) has healing effects on the intestinal mucosa and improves survival when administered systemically after the onset of preclinical sepsis. The intestine plays a key role in this improvement in mortality as transgenic mice that overexpress EGF only in the villus epithelium also have a survival benefit. However, EGF also has extraintestinal effects mediated via the adaptive immune system. To determine whether systemic EGF alters the T-cell response following sepsis, splenic flow cytometry was assayed in mice randomized to receive systemic EGF or vehicle. CD4 + T-cell frequency was increased, whereas CD8 + T-cell frequency was decreased in septic mice following EGF, associated with a significant decrease in activated CD4 + T memory cells. Further, the exhaustion marker TIGIT was significantly upregulated following EGF on both conventional and regulatory CD4 + T cells. Based on these findings and known crosstalk between the gut epithelium and the adaptive immune system, we asked whether the beneficial effects of systemic and intestine-specific EGF were dependent on the presence of an adaptive immune system. Rag1-/- mice lacking mature lymphocytes were randomized to receive either systemic EGF or vehicle following sepsis. In contrast to its beneficial effect in immunocompetent mice, EGF markedly worsened 7-day mortality in Rag1 -/- mice. Similar to immunocompetent mice, EGF decreased gut epithelial apoptosis in Rag1 -/- mice but lost its ability to improve either permeability or villus length. Further, when transgenic mice that overexpress intestine-specific EGF were crossed to Ra g1 -/- mice, intestine-specific EGF had no impact on survival following sepsis despite retaining its ability to decrease sepsis-induced gut epithelial apoptosis and permeability. Thus, although EGF is a potentially novel therapeutic in sepsis via improving gut integrity, EGF also changes T-cell biology, and the survival advantage of EGF following sepsis is dependent, at least in part, on interactions between the gut and the adaptive immune system.
参考来源
- Davis CM, Fitzgerald CA, Jaffree LS, et al. The Role of Epidermal Growth Factor in Mediating Survival in Mouse Sepsis is Dependent Upon an Intact Adaptive Immune System. Shock. 2025. PMID: 40368370. doi:10.1097/SHK.0000000000002627
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。